Omalizumab for treatment of refractory urticaria in a patient with metastatic uveal melanoma receiving tebentafusp
Dermatology Reports · 06.05.2026
DOI: 10.4081/dr.2026.10366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology Reports, online erschienen am 06.05.2026. Verfasst von Faith Simmonds und 4 weiteren Autor:innen. Beteiligte Einrichtung: Vagelos College of Physicians and Surgeons, Columbia University, New York, NY. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Tebentafusp is an immune-mobilizing monoclonal T-cell receptor approved for the treatment of metastatic uveal melanoma. While this agent improves outcomes in patients with unresectable or metastatic uveal melanoma, tebentafusp commonly results in dermatologic cutaneous toxicities. Herein, we present a case of a 32-year-old patient diagnosed with juxtapapillary choroidal melanoma of the left eye with metastases to the liver who developed a diffuse urticarial skin reaction to tebentafusp that was successfully treated with omalizumab.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
- Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, NY.
- Department of Dermatology, Columbia University Irving Medical Center, New York, NY.
Zitieren
APA
Simmonds, F., Kashua, V., McDonnell, D., El-Ashmawy, M., & Coromilas, A. J. (2026). Omalizumab for treatment of refractory urticaria in a patient with metastatic uveal melanoma receiving tebentafusp. Dermatology Reports. https://doi.org/10.4081/dr.2026.10366
Vancouver
Simmonds F, Kashua V, McDonnell D, El-Ashmawy M, Coromilas AJ. Omalizumab for treatment of refractory urticaria in a patient with metastatic uveal melanoma receiving tebentafusp. Dermatology Reports. 2026. doi:10.4081/dr.2026.10366
BibTeX
@article{Simmonds2026,
author = {Simmonds, Faith and Kashua, Veronica and McDonnell, Diana and El-Ashmawy, Mariam and Coromilas, Alexandra J},
title = {Omalizumab for treatment of refractory urticaria in a patient with metastatic uveal melanoma receiving tebentafusp},
journal = {Dermatology Reports},
year = {2026},
doi = {10.4081/dr.2026.10366}
}
EUVIMED